Sanofi Pasteur dengue vaccine approved in Costa Rica
Jun 24, 2016, at 05:20 am
Kolkata/Costa Rica, June 23 (IBNS): Sanofi Pasteur, Sanofi's vaccine division, announced on Thursday that the National Ministry of Health of Costa Rica has approved Sanofi Pasteur's tetravalent dengue vaccine, Dengvaxia, to protect individuals 9 to 45 years of age living in endemic areas against all four serotypes of dengue.
Sanofi Pasteur's Dengue vaccine approved in Philippines
Dec 23, 2015, at 08:34 pm
Kolkata/Lyon, France, Dec 23 (IBNS) Sanofi Pasteur, the vaccines division of Sanofi, announced on Wednesday that the Philippines have granted marketing approval to Dengvaxia, making it the first vaccine to be licensed for the prevention of dengue in Asia.